submit to the journals

Videos: Interstitial Lung Disease

Mary E Strek (University of Chicago, Chicago, IL, US) brings us up to speed on important aspects of autoimmune lung diseases. Questions 1. How prevalent are autoimmune lung diseases? (0:10) 2....
Jonathan H Chung (University of Chicago, Chicago, IL, US) shares his expert insights on radiology imaging of interstitial lung diseases. Questions 1. What are the most radiologic characteristics...
Simon Walsh (King’s College NHS Foundation Trust, King's College London, London, UK) discusses the background and findings of his late-breaking presentation entitled: A Deep Learning Algorithm for Cla...
Yohannes Ghebre (Baylor College of Medicine, Houston, TX, US) discusses the rationale and clinical evidence to date for using proton pump inhibitors (PPIs) to treat idiopathic pulmonary fibrosis (IPF)...
The FDA has fast-tracked Ofev and Esbriet as approved medications for IPF. Together with stem cell therapy, we're closer to finding a cure for IPF.
Dr. Aryeh Fischer discusses highlights of a session held at the 2015 ATS annual conference which focused on several topics related to the management of ILD and related diseases. In addition, he discus...
This video segment serves as a short introduction and educational lesson for our MedNet21 webcast on Evaluation and Treatmentof Idiopathic Pulmonary Fibrosis
Alison Morris, MD, a pulmonologist with the Comprehensive Lung Center at UPMC, is the primary investigator for the NIH-funded Lung Microbiome Project, and discusses how this ongoing research can help...
Dr Toby Maher discusses guidelines for management of idiopathic pulmonary fibrosis (IPF).
Interstitial Lung Disease in Scleroderma - Lessons from idiopathic pulmonary fibrosis and implications for future therapies for scleroderma related interstitial lung disease.